AZ cuts hundreds of scientists

Drug maker AstraZeneca is pink-slipping approximately 550 Wilmington, Delaware-based researchers and their support staff in a move to help balance the company's books and save it $1.9 billion per year by 2014. Image: B.gliwa via Wikipedia CommonsThe company told the linkurl:__Philadelphia Inquirer__;http://www.philly.com/philly/business/86127882.html yesterday (March 3rd) that the layoffs are part of a plan to shutter an entire research group, focused on identifying candidate compounds for psyc

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Drug maker AstraZeneca is pink-slipping approximately 550 Wilmington, Delaware-based researchers and their support staff in a move to help balance the company's books and save it $1.9 billion per year by 2014.
Image: B.gliwa via Wikipedia Commons
The company told the linkurl:__Philadelphia Inquirer__;http://www.philly.com/philly/business/86127882.html yesterday (March 3rd) that the layoffs are part of a plan to shutter an entire research group, focused on identifying candidate compounds for psychiatric diseases. The staff in Wilmington will lose their jobs by the end of 2011. The impending cuts likely explain why the pharmaceutical company declined to quantify its new R&D hires when we recently requested it for an upcoming project. In mid-2008, AstraZeneca's Vice President of Continuous Improvement and Business Performance, Karen Gotting-Smith, linkurl:told;http://www.the-scientist.com/2008/9/1/69/1/ __The Scientist__ she hoped her newly created position would help the company streamline its drug development process while increasing quality and lowering costs. "My role now is to work with a very large organization, globally complex, with challenging diseases that they're developing drugs for to overcome those challenges," Gotting-Smith told __The Scientist__. "We all have to rise to the challenge of expectations."
**__Related stories:__***linkurl:Expert advice on surviving $ mess;http://www.the-scientist.com/blog/display/55191/
[13th November 2008]*linkurl:Chasing Challenges;http://www.the-scientist.com/2008/9/1/69/1/
[September 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform